These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 27548417)

  • 21. Failure of Dual Antimicrobial Therapy in Treatment of Gonorrhea.
    Fifer H; Natarajan U; Jones L; Alexander S; Hughes G; Golparian D; Unemo M
    N Engl J Med; 2016 Jun; 374(25):2504-6. PubMed ID: 27332921
    [No Abstract]   [Full Text] [Related]  

  • 22. Solithromycin versus ceftriaxone plus azithromycin for the treatment of uncomplicated genital gonorrhoea (SOLITAIRE-U): a randomised phase 3 non-inferiority trial.
    Chen MY; McNulty A; Avery A; Whiley D; Tabrizi SN; Hardy D; Das AF; Nenninger A; Fairley CK; Hocking JS; Bradshaw CS; Donovan B; Howden BP; Oldach D;
    Lancet Infect Dis; 2019 Aug; 19(8):833-842. PubMed ID: 31196813
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Remarkable increase of Neisseria gonorrhoeae with decreased susceptibility of azithromycin and increase in the failure of azithromycin therapy in male gonococcal urethritis in Sendai in 2015.
    Yasuda M; Ito S; Hatazaki K; Deguchi T
    J Infect Chemother; 2016 Dec; 22(12):841-843. PubMed ID: 27578029
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of gonococcal infection: when one drug is not enough.
    Kransdorf LN; Kling JM; Mayer AP
    J Womens Health (Larchmt); 2014 Jul; 23(7):627-8. PubMed ID: 24918549
    [No Abstract]   [Full Text] [Related]  

  • 25. Neisseria gonorrhoeae with reduced susceptibility to azithromycin--San Diego County, California, 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 May; 60(18):579-81. PubMed ID: 21566558
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gonorrhea Treatment Failures With Oral and Injectable Expanded Spectrum Cephalosporin Monotherapy vs Dual Therapy at 4 Canadian Sexually Transmitted Infection Clinics, 2010-2013.
    Singh AE; Gratrix J; Martin I; Friedman DS; Hoang L; Lester R; Metz G; Ogilvie G; Read R; Wong T
    Sex Transm Dis; 2015 Jun; 42(6):331-6. PubMed ID: 25970311
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Australian Gonococcal Surveillance Programme, 1 April to 30 June 2015.
    Lahra MM; Enriquez RP;
    Commun Dis Intell Q Rep; 2015 Dec; 39(4):E628-30. PubMed ID: 26779739
    [No Abstract]   [Full Text] [Related]  

  • 28. Cephalosporin and azithromycin susceptibility in Neisseria gonorrhoeae isolates by site of infection, British Columbia, 2006 to 2011.
    Hottes TS; Lester RT; Hoang LM; McKay R; Imperial M; Gilbert M; Patrick D; Wong T; Martin I; Ogilvie G
    Sex Transm Dis; 2013 Jan; 40(1):46-51. PubMed ID: 23250301
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Update on Treatment Options for Gonococcal Infections.
    Lancaster JW; Mahoney MV; Mandal S; Lawrence KR
    Pharmacotherapy; 2015 Sep; 35(9):856-68. PubMed ID: 26343813
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High prevalence of ciprofloxacin-resistant gonorrhea among female sex workers in Kampala, Uganda (2008-2009).
    Vandepitte J; Hughes P; Matovu G; Bukenya J; Grosskurth H; Lewis DA
    Sex Transm Dis; 2014 Apr; 41(4):233-7. PubMed ID: 24622633
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gonorrhea treatment practices in the STD Surveillance Network, 2010-2012.
    Kerani RP; Stenger MR; Weinstock H; Bernstein KT; Reed M; Schumacher C; Samuel MC; Eaglin M; Golden M
    Sex Transm Dis; 2015 Jan; 42(1):6-12. PubMed ID: 25504294
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fluoroquinolone-resistance in Neisseria gonorrhoeae, Hawaii, 1999, and decreased susceptibility to azithromycin in N. gonorrhoeae, Missouri, 1999.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2000 Sep; 49(37):833-7. PubMed ID: 11012233
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CDC update on gonorrhea: expand treatment to limit resistance.
    Campos-Outcalt D
    J Fam Pract; 2011 Dec; 60(12):736-40. PubMed ID: 22163356
    [No Abstract]   [Full Text] [Related]  

  • 34. Retrospective analysis of antimicrobial susceptibility trends (2000-2009) in Neisseria gonorrhoeae isolates from countries in Latin America and the Caribbean shows evolving resistance to ciprofloxacin, azithromycin and decreased susceptibility to ceftriaxone.
    Starnino S; ; Galarza P; Carvallo ME; Benzaken AS; Ballesteros AM; Cruz OM; Hernandez AL; Carbajal JL; Borthagaray G; Payares D; Dillon JA
    Sex Transm Dis; 2012 Oct; 39(10):813-21. PubMed ID: 23001269
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of New Antimicrobials for Urogenital Gonorrhea Therapy: Clinical Trial Design Considerations.
    Hook EW; Newman L; Drusano G; Evans S; Handsfield HH; Jerse AE; Kong FYS; Lee JY; Taylor SN; Deal C
    Clin Infect Dis; 2020 Mar; 70(7):1495-1500. PubMed ID: 31538646
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trends of sexually transmitted diseases and antimicrobial resistance in Neisseria gonorrhoeae.
    Matsumoto T
    Int J Antimicrob Agents; 2008 Feb; 31 Suppl 1():S35-9. PubMed ID: 18164598
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Non-viral sexually transmitted infections - Epidemiology, clinical manifestations, diagnostics and therapy : Part 1: Gonococci].
    Nenoff P; Manos A; Ehrhard I; Krüger C; Paasch U; Helmbold P; Handrick W
    Hautarzt; 2017 Jan; 68(1):43-49. PubMed ID: 27981386
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combination therapy for gonorrhoea: in vitro synergy testing.
    Pereira R; Cole MJ; Ison CA
    J Antimicrob Chemother; 2013 Mar; 68(3):640-3. PubMed ID: 23152483
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Neisseria gonorrhoeae infections].
    Furuya R; Tanaka M
    Nihon Rinsho; 2009 Jan; 67(1):129-35. PubMed ID: 19177762
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gonorrhoea in 21st century--international and Polish situation.
    Serwin AB; Koper M; Unemo M
    Przegl Epidemiol; 2014; 68(1):39-44, 127-31. PubMed ID: 25004630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.